The biggest technology story of 2013 is one of the biggest stories of the year, period. It has had serious implications in the United States and around the world, and half a year later its true ...

Top tech stories 2013 — Snapchat leads rise of messaging apps: It was dismissed as a simple app for sexting teens, but Snapchat, like other upstart messaging apps, has a fast-growing user base.

Top tech stories 2013 — Wearable tech goes mainstream: The age of wearable technology is not here yet, but in 2013 a crop of protoypes took their first unsteady steps towards common use.

The top 10 CNN Heroes of 2013 each receive $50,000 for their efforts to help change the world They were honored during a special awards show, "CNN Heroes: An All-Star Tribute" ...

Top 10 business stories December 17, 2001: 2:17 p.m. ET It was a challenging year for corporate America, investors and consumers. by Shelly K. Schwartz ...

CNN's Candy Crowley and her guests offered their top 10 political stories of the year Sunday on "State of the Union," ranging from the White House to the Hill to the Supreme Court — and overseas.

Today on CNN 10, we head to Hong Kong, where 45 people were sentenced to prison for violating a new national security law put in place by China after anti-government protests took over the city in ...

CNN. CNN 10: The big stories of Monday 2/10, explained in 10 minutes. Posted: February 10, 2025 ... See the top 10. 41 States That Won’t Tax Social Security Benefits in 2025.

Chase Roberts heads into 2025 as the go-to wide receiver for the BYU football program. The senior from American Fork is also ...

TCTMD’s Top 10 Most Popular Stories for January 2025. By Shelley Wood January 31, 2025. News Opinion Editor's Corner. TCTMD’s Top 10 Most Popular Stories for December 2024. By Caitlin E. Cox December ...

World's best: Top 10 airlines named: Annual survey of millions of passengers ranks the planet's best airlines. June 7, 2005: 1:47 PM EDT By Gordon T. Anderson, CNN/Money staff writer ...

For May, TCTMD’s top 10 stories highlight the field’s greatest hits—TAVI in asymptomatic patients, the vagaries of statin decision-making, embolic protection woes, the latest on SGLT2 inhibitors, ...